CLINICAL_TRIALS
trial_result
· 2018-10-16
Clinical Trial Update: A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus [Phase 1]
Summary
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of PF-06293620 in subjects with type 2 diabetes mellitus completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2018-10-16